
Medicine and Health
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
H. Ma, X. Zhang, et al.
This groundbreaking study reveals two hetero-bivalent nanobodies that effectively neutralize various SARS-CoV-2 variants, including Omicron. Researchers, including Huan Ma, Xinghai Zhang, and Peiyi Zheng, highlight the potential of aRBD-2-5-Fc for COVID-19 prevention and treatment, demonstrating significant protection in hamsters.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.